Abstract. Multiple system atrophy (MSA) is a neurodegenerative disorder that predominantly affects motor-related neuroanatomic structures. The role of microglia in MSA is unknown. To address this issue, we conducted quantitative image studies on the brains from 13 cases of MSA, comprising 8 cerebellar and 5 parkinsonian variants. Microglial and glial cytoplasmic inclusion (GCI) burdens were determined with image analysis on brain sections immunostained with antibodies to HLA-DR and alpha-synuclein. Many activated microglia, as well as GCIs, were noted in motor-related structures, including the cerebellar input, extrapyramidal motor, and pyramidal motor structures, but not in the cerebellar output structures. This result indicates that microglial activation, as well as the distribution of GCIs, is system-specific in MSA. The correlation analysis between the microglial and GCI burdens yielded variable yet significant correlations in the cerebellar input, extrapyramidal motor, and pyramidal motor systems, but not in the cerebellar output system. This result suggests that microglial activation is at least partly determined by GCIs or oligodendroglial alpha-synuclein in specific neuroanatomic systems affected in MSA. Taken together, considering the known toxic effects of microglia in neurodegenerative diseases, microglia may play a part in the development of system-specific tissue injuries, contributing to the system-bound clinical and pathological phenotypes.
INTRODUCTION
Multiple system atrophy (MSA) is a non-hereditary neurodegenerative disorder that predominantly affects motor-related neuroanatomic structures in the central nervous system (1, 2) . MSA is subdivided into 2 variants based on its predominant motor disorder: MSA-C, a cerebellar variant; and MSA-P, a parkinsonian variant (1) . Glial cytoplasmic inclusions (GCIs), which are argyrophilic oligodendroglial inclusions composed of aggregates of non-membrane-bound filaments and granular materials (3) , are commonly accepted as the histological hallmark of MSA (1-3). One of the major constituent proteins of GCIs is alpha-synuclein, a 140-amino acid protein that is predominately localized in pre-synaptic nerve terminals (4, 5) . GCIs or alpha-synuclein are considered to be among the cardinal pathologic substrates of MSA, and now MSA is placed under the umbrella term ''alpha-synucleinopathies'' as are Parkinson disease and dementia with Lewy bodies (6) (7) (8) .
Recently, microglia have been implicated in a variety of neurodegenerative disorders such as Alzheimer disease (AD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) (9) (10) (11) (12) (13) . Activation of microglia has been documented in MSA (14, 15) ; however, information on microglia in MSA is extremely limited. Microglial activation can be used as an index of neurodegeneration since microglia respond to tissue injuries in a host of brain disorders (16) . The purpose of this study is to reveal the pathologic behaviors of microglia in MSA and to address the importance of microglial activation in the disease pathogenesis.
MATERIALS AND METHODS

Case Material
Thirteen cases of MSA (8 cases of MSA-C and 5 cases of MSA-P) were studied. The diagnoses of MSA were confirmed at the Tokyo Metropolitan Neurological Hospital and Department of Pathology, according to the published diagnostic criteria (1) . Briefly, all cases were diagnosed as definite MSA by pathological confirmation of a high density of GCIs in association with degenerative changes in the nigrostriatal and olivopontocerebellar pathways. The cases were further designated as MSA-C if cerebellar features predominated, or MSA-P if parkinsonian features predominated. To rule out coincident non-MSA degenerative pathology, silver impregnation methods (Bodian and Gallyas preparations) and immunostaining (tau, beta-amyloid, ubiquitin, alpha-synuclein) were applied to all cases, and no non-MSA degenerative pathology (tauopathy, non-MSA alpha-synucleinopathy, or intranuclear inclusions suggestive of hereditary spinocerebellar ataxias) was identified. Differential diagnoses from these non-MSA neurodegenerative diseases were based on the published criteria (17) (18) (19) (20) (21) (22) . Table 1 lists the clinical features of the cases studied. MSA-C  MSA-C  MSA-C  MSA-C  MSA-C  MSA-C  MSA-C  MSA-C   57  58  60  63  64  69  73  74   f  m  m  m  m  m  m  m   1138  1280  1239  1160  1059  1124  950  1285   9  10  7  10  19  10 * Average Ϯ standard deviation. Abbreviations: PMI, postmortem interval; MSA-C, multiple system atrophy-cerebellar; MSA-P, multiple system atrophy-parkinsonian.
with adjacent structures; midbrain at the level of the red nucleus; pons containing the superior cerebellar peduncle; medulla oblongata including the hypoglossal nucleus and inferior olivary nucleus; and cerebellum at the level of the dentate nucleus. Hematoxylin and eosin (H&E) and Luxol fast blue/periodic acid-Schiff (LFB/PAS) stains were applied to all sections for routine histologic evaluation.
Single-and Double-Labeling Immunohistochemistry
Sections were deparaffinized and rehydrated, incubated in 50 mM TRIS-buffered saline (TBS; pH 7.8) containing 0.3% hydrogen peroxide, washed in TBS and processed for antigen retrieval pretreatment using hydrolytic autoclaving or microwaving. The sections were treated in 5% non-fat milk and incubated with the following primary antibodies: monoclonal antibodies directed against HLA-DR (LN-3; 1:5; ICN Biomedicals, Inc., Aurora, OH) or CD68 (KP1; 1:300; Dako, Carpinteria, CA) for microglia (11, 23) , and a rabbit polyclonal anti-alpha-synuclein antibody (1:30; Courtesy of Dr. T. Iwatsubo, Tokyo, Japan) for labeling of GCIs. The subsequent staining was conducted with an immunoperoxidase method (LSAB 2 Kit or Envisionϩ; Dako) using diaminobenzidine (DAB) as the chromogen. The sections immunostained with KP1 were counterstained with LFB. The sections were dehydrated with serially increasing concentrations of ethanol and finally with xylene and were coverslipped.
To examine the direct spatial relationship between microglia and GCIs, KP1 and the anti-alpha-synuclein antibody were simultaneously applied to representative sections. The antibodies were detected with species-specific horseradish peroxidase-and alkaline phosphatase-labeled secondary antibodies (1:500; Southern Biotechnology, Birmingham, AL), and were then visualized with DAB and fuchsin, respectively.
Computer-Assisted Quantitative Image Analysis
Prior to image analysis, the neuroanatomic systems concerned were selected as follows: 1) pyramidal motor (7 areas): primary motor cortex, precentral white matter, internal capsule (lateral to the ventrolateral nucleus of the thalamus), cerebral peduncle (mid-third portion), pontine base (longitudinal fibers), medullary pyramid, and hypoglossal nucleus; 2) extrapyramidal motor (7 areas): head of the caudate nucleus, globus pallidus and putamen (2 coronal levels: anterior and posterior, at the level of the amygdala and thalamus, respectively), subthalamic nucleus, and substantia nigra (lateral half); 3) cerebellar output (5 areas): dentate nucleus, dentate hilus, superior cerebellar peduncle, red nucleus, and ventrolateral nucleus of the thalamus; 4) cerebellar input (5 areas): pontine base (horizontal fibers), inferior olivary nucleus, inferior cerebellar peduncle, middle cerebellar peduncle, and cerebellar white matter.
Two adjacent sections from a neuroanatomic area that were single-immunostained with the anti-alpha-synuclein antibody and LN-3 (an anti-HLA-DR antibody) were used for this analysis; the sections immunostained with the former were counterstained with hematoxylin, while those immunostained with the latter were not. An identical portion was selected by marking the neuroanatomic area on the slide manually with a fine point marker. At low magnification, a representative field with a high density of alpha-synuclein-or HLA-DR-immunoreactive products was identified within the marked area. At high magnification (ϫ400), this field was scanned by a light microscope (Nikon Optiphot-2; Nikon, Tokyo, Japan) equipped with a digital camera (Fujix digital camera HC-2500; Fuji photo film, Tokyo, Japan), and 4 adjacent non-overlapping microscopic fields (totaling approximately 0.38 mm 2 ) were randomly captured through an image capture software system (Photograb-2500; Fuji photo film) into a personal computer (Power Macintosh G3). To determine the GCI burden, alpha-synuclein-positive GCIs accompanying conspicuous hematoxylin-stained oligodendroglial nuclei were manually counted on captured images mounted in the image software (Photoshop 6.0; Adobe, San Jose, CA). To determine the microglial burden, the images captured were analyzed with image analysis software (NIH image 1.62; National Institutes of Health) by first converting them to gray-scale images and then detecting HLA-DR-immunoreactive pixels by intensity. A fractional area density of HLA-DR-immunoreactive pixels to total pixels of the whole field (1,280,000 pixels/field) was yielded.
Statistical Analysis
The data were analyzed with a computer software system (Stat-View 4.0; Abacus Concept; Berkeley, CA). A MannWhitney U-test was used for group comparisons. For lesion burden-to-burden correlation analysis between the GCI and microglial burdens, both of which have 4 variables in each neuroanatomic area, the variables were averaged to yield a representative figure and were analyzed using simple regression analysis.
RESULTS
Single-Labeling Immunohistochemical Results
Overall, CD68-or HLA-DR-immunoreactive microglia showed morphologic changes consistent with microglial activation (11) . Many activated microglia, amoeboid in shape and often aggregated to form clusters, were noted not only in perivascular regions but also in the brain parenchyma. Microglial activation was preferentially noted in the cerebellar input ( Fig. 1a ) and extrapyramidal motor (Fig. 1b) systems. Phagocytosis of degenerating myelin by activated microglia was a common feature (Fig. 1c) . The pyramidal motor system was also a target for microglial activation, especially in white matter areas (Fig. 1d) . In contrast to these 3 neuroanatomic systems, microglia were mostly in a ''resting state'' (11) in the cerebellar output system (Fig. 1e) . In general, microglial activation was more pronounced in severely affected areas. However, in some instances there seemed to be a discrepancy between the degree of microglial activation and that of other pathologic changes in the sense that, despite the presence of severe neuronal loss, rarefaction of the neuropil, or myelin loss, microglial activation seemed much less pronounced. This was particularly true in the putamen or cerebellar white matter. Conversely, where pathologic changes were relatively mild on H&E-or LFB/PAS-stained sections, microglial activation would sometimes seem disproportionally pronounced (Fig. 1f) . In the non-motor-related neuroanatomic areas studied (e.g. in some areas of the frontal association or insular cortices), microglial activation was not a prominent feature. The morphology of activated microglia was identical between MSA-C and MSA-P.
The morphology and neuroanatomic distribution of GCIs were consistent with previous studies (3, 24, 25) .
In both MSA-C and MSA-P, alpha-synuclein-positive GCIs were numerous in the cerebellar input, extrapyramidal motor, and pyramidal motor systems. Fewer GCIs were noted in the cerebellar output system. In general, the count of GCIs was proportional to the degree of tissue damage; however, there was a tendency to note fewer GCIs if the damage was severe, for instance, as was seen in the putamen or cerebellar white matter. In our cases, alpha-synuclein-positive neuronal cytoplasmic inclusions or neuropil threads were not a predominant feature, being noted in just a few cases.
Double-Labeling Immunohistochemical Results
Microglia and GCIs were sometimes located in close proximity to each other, especially in severely affected areas. Activated microglia that were in direct contact with GCIs were sporadically noted (Fig. 2) . GCIs inside the microglial cytoplasm were not identified.
Quantitative Computer-Assisted Image Analysis
Microglial Burden: Microglial burden, as determined by fractional area density of HLA-DR-immunoreactive pixels, showed a system-specific distribution ( Table 2 ). The microglial burden was the most pronounced in the cerebellar input system, followed by the pyramidal motor and extrapyramidal motor systems. The cerebellar output system showed the smallest microglial burden. When all the systems were combined for analysis, there was no difference between the microglial burdens of MSA-C and MSA-P.
GCI Burden: GCI burden, as determined by the GCI count, showed a system-specific distribution as well (Table 3). The cerebellar input system showed the greatest GCI burden, followed by the extrapyramidal motor and pyramidal motor systems. The smallest GCI burden belonged to the cerebellar output system. The GCI burden showed some difference when compared between MSA-C and MSA-P: The cerebellar output system contained more GCIs in MSA-C than in MSA-P, while the cerebellar input system contained more GCIs in MSA-P than in MSA-C. When all the systems were combined for analysis, the GCI burden showed no difference between MSA-C and MSA-P.
Correlations Between Microglial and GCI Burdens: In this analysis the correlation coefficients were variable, but were significant in a system-specific manner (Table  4 ). In the extrapyramidal motor system the correlation was significant in MSA-C and MSA-P, as well as in MSA (Fig. 3a) . In the cerebellar input system the correlation was significant in MSA-P and MSA (Fig. 3b) . In the pyramidal motor system the correlation was significant in MSA-P alone. Interestingly, in the cerebellar input and pyramidal motor systems of MSA-C, where numerous ← cerebellum. LN-3 immunostain; original magnification: ϫ400. f: In a portion of the putamen where pathologic changes are less severe, microgliosis is sometimes confined to white matter bundles. Medioventral part of the putamen, KP1 immunostain counterstained with LFB; original magnification: ϫ200. activated microglia and GCIs were present, the correlation was not significant. A significant correlation was absent in the cerebellar output system in MSA-C, MSA-P and MSA. The correlation coefficients were generally higher in MSA-P than in MSA-C. When all the systems were combined for analysis, the microglial and GCI burdens were significantly correlated in MSA-C, MSA-P, and MSA.
Since GCIs are predominantly located in white matter, and yet gray matter is also a target for neurodegeneration in MSA, we analyzed the microglial and GCI burdens grouped by neuroanatomic region subdivided into gray and white matter (Table 5 ). Among MSA-C, MSA-P, and MSA, the correlation coefficients were variable, but were unanimously significant in both gray matter and white matter. Compared in dichotomy between gray matter and white matter, the correlation coefficients yielded were similar in both compartments.
DISCUSSION
MSA is a neurodegenerative disorder that predominantly affects motor-related neuroanatomic structures and systems in a hierarchical order. In the recently established consensus criteria (1), 4 salient clinical features (autonomic failure, parkinsonism, cerebellar ataxia, and pyramidal signs) were suggested as the 4 clinical domains for the diagnosis of MSA; the first 3 domains (autonomic failure, parkinsonism, and cerebellar ataxia) were defined as definite diagnostic features, whereas pyramidal signs were considered to be less important than abnormalities in the other domains.
Neuroimaging studies account for this clinical profile of MSA. For example, magnetic resonance imaging (MRI) shows reduced volume of the putamen, cerebellum, and brainstem and abnormal signal intensities in these affected areas (2, 26, 27) .
The neuropathology of MSA, comprised of neuronal loss, gliosis, microvacuolation and myelin loss, shows a system-bound degeneration that corresponds well to the clinical and neuroradiologic profiles (2, 24) . The extrapyramidal motor system, most notably the substantia nigra (ventrolateral part) and putamen (posterolateral part), and to a lesser extent, the caudate nucleus and pallidum, is most invariably involved (1, 24, 28) . The cerebellar input system (i.e. neuroanatomic structures encompassing the olivopontocerebellar pathway, including the middle and inferior cerebellar peduncles, pontine nucleus, inferior olivary nucleus, and cerebellar cortex) is also an easy target for degeneration (1, 28) . The pyramidal motor system, including the primary motor cortex and its descending white matter tracts, is also preferentially involved (2, 29) . In contrast, the cerebellar output system, including the dentate nucleus and its outflow pathway, is generally far less affected (25, 28) .
The distribution of GCIs, the histological hallmark of MSA, is also system-bound as shown in a previous study (25) . GCIs are predominantly encountered in motor-related neuroanatomic structures and systems. GCI-rich structures are located in the pyramidal motor (primary motor cortex and higher motor areas of cerebral cortices, internal capsule, cerebral peduncle, pontine base, and motor nuclei of the brainstem) and extrapyramidal motor (striatum and pallidum) systems. GCIs are abundantly located in the cerebellar input structures as well, but not in the cerebellar output structures. This rule of GCI distribution has been confirmed in the present study (Table 3) .
We focused on the pathologic behaviors of microglia in motor-related structures in MSA. The microglia had features consistent with an activated state, based on both morphologic criteria (shorter and thicker cell processes, and enlarged, ameboid cell bodies) and their immunophenotype, particularly the expression of HLA-DR (11, 23) . The mode of microglial activation was not arbitrary but was system-specific (Table 2) , consistent with the known pattern of system degeneration in MSA. Average Ϯ standard deviation in %; * Mann-Whitney U-test, p Ͻ 0.01. Abbreviations: MSA, multiple system atrophy; MSA-C, multiple system atrophy-cerebellar; MSA-P, multiple system atrophy-parkinsonian.
An analogous finding was obtained in a previous study dealing with microglial activation in PSP and CBD (13) , where the microglial burden was determined in a similar method to the present study. In PSP, microglial activation was prominent in the pyramidal motor, extrapyramidal motor, and cerebellar output systems, whereas in CBD this was true in the multimodal association, pyramidal motor, and extrapyramidal motor systems. These neuroanatomic systems correspond well to those specifically involved in PSP or CBD (17) . Taken together with our results, microglial activation is system-specific in MSA as well as in PSP and CBD.
We have performed correlation analyses between microglial and GCI burdens in MSA. The correlation coefficients were variable, and yet significant in a systemspecific manner. The correlation was significant in the extrapyramidal motor and cerebellar input systems (Table  4) . These are the 2 systems that are specifically affected in MSA. Findings analogous to this one in MSA were also obtained for PSP and CBD (13) . In PSP, the microglial and hyperphosphorylated tau burdens were significantly correlated in the pyramidal motor, extrapyramidal motor, limbic, and oculomotor systems, whereas in CBD this was true in the multimodal association, somatosensory, pyramidal motor, extrapyramidal motor, and oculomotor systems (13) . These are the neuroanatomic systems that are specifically affected in PSP or CBD (17) . Taken together, it could be hypothesized that microglial activation is at least partly determined by the burden of cardinal pathologic substrates, i.e. alpha-synuclein (or GCIs in the present study) in MSA or hyperphosphorylated tau in PSP and CBD. Furthermore, this proposition is true for only the neuroanatomic systems that are specifically involved in these neurodegenerative disorders.
An important role for microglia has been shown in a variety of neurodegenerative disorders (9-13). Microglia can produce tissue injuries through the secretion of inflammatory cytokines, complement proteins, free radicalrelated toxic molecules, and as yet unidentified neurotoxic products (11, (30) (31) (32) . Microglia may produce not only a direct toxic effect, but also an indirect effect through astrocytes (11, 33) .
Together, the system degeneration of MSA as well as that of PSP and CBD may be partially mediated, or even Average Ϯ standard deviation in number/high power field (0.094 mm 2 ). * Mann-Whitney U-test, p Ͻ 0.01. Abbreviations: MSA, multiple system atrophy; MSA-C, multiple system atrophy-cerebellar; MSA-P, multiple system atrophy-parkinsonian. ; ** p Ͻ 0.01. Abbreviations: GCI, glial cytoplasmic inclusion; MSA, multiple system atrophy; MSA-C, multiple system atrophy-cerebellar; MSA-P, multiple system atrophyparkinsonian; ns, not significant. amplified, by activated microglia; in other words, microglial activation may contribute to system-specific tissue injuries in MSA, PSP, or CBD. Recently, the role of anti-inflammatory drugs has been highlighted in the prevention and amelioration of AD (34, 35) . Given the above findings in MSA, studies on anti-inflammatory agents for management of MSA could be warranted.
One of the interesting findings in the present study was the absence of a significant correlation between microglial and GCI burdens in the cerebellar input and pyramidal motor systems of MSA-C (Table 4) , despite the high population of activated microglia and GCIs in these areas (Tables 2, 3 ). This result may indicate that in certain systems, microglia may react to pathology that is not directly linked to GCIs or oligodendroglial alpha-synuclein in MSA.
For example, non-oligodendroglial alpha-synucleinpositive inclusions (i.e. neuronal cytoplasmic inclusions or neuropil threads, to name a few) are commonly noted in cerebellar input structures of the pons or medulla (36) . It was previously demonstrated that biochemical modifications of alpha-synuclein are more widespread than histopathologically visible in MSA (37) . In another study using antibodies that detect an epitope expressed in degenerating myelin, it was suggested that white matter pathology in MSA may be more widespread than had previously been thought (38) . Based on these findings, in addition to ours, non-GCI inclusions or abnormal alphasynuclein and degenerating myelin that is more widespread than meets the eye, can induce microglial activation. An analogous finding was also obtained for the brainstem of PSP, where microglial activation was poorly correlated with tau pathology despite the presence of severe microgliosis and tau lesions (13) .
We studied microglial and GCI burdens by subgrouping MSA into 2 clinical variants, MSA-C and MSA-P. The GCI burden was different in the 2 variants in some neuroanatomic systems. In the cerebellar output, GCIs were more abundant in MSA-C than in MSA-P, while in the cerebellar input, GCIs were more abundant in MSA-P than in MSA-C (Table 3 ). The neuroanatomic systems where the microglial and GCI burdens were significantly correlated were not the same between MSA-C and MSA-P ( Table 4 ). The correlation coefficients thus yielded were different and generally higher in MSA-P than in MSA-C (Tables 4, 5 ). These results may suggest that the mode of degeneration is not necessarily the same between MSA-C and MSA-P.
Macroscopically, MSA-C brains show striking atrophy of the pontine base and medulla, as well as the middle and inferior cerebellar peduncles, whereas MSA-P brains show atrophy and a spongy appearance of the posterolateral putamen (2, 24) . Microscopically, MSA-C brains have a severe pathology in the infratentorial compartment including the olivopontocerebellar pathway, while MSA-P brains are more affected in the nigrostriatal pathway, most notably the putamen (39, 40) . This difference may be more evident at an early stage of the disease, when cerebellar or parkinsonian features are present in isolation; the difference may become unclear when the 2 features get overlapped as the disease deteriorates. In other words, in MSA-P the extrapyramidal motor system (nigrostriatal pathway) is damaged earlier than the cerebellar input system (olivopontocerebellar pathway), while in MSA-C the order is reversed. It was suggested that GCI formation may be an early event of the disease and that GCIs tend to be less prominent in severely affected areas or in cases of long-standing duration (25, 41, 42) . Thus, to take an example of the cerebellar input system in the present study, the less numerous GCIs noted in MSA-C than in MSA-P could be interpreted as kind of a ''burntout'' phenomenon. Or, the more numerous GCIs noted in MSA-C than in MSA-P in the cerebellar output system may indicate the earlier involvement of the system in MSA-C compared to MSA-P.
Neuroimaging studies have provided inconclusive evidence as to whether there are substantial differences in the 2 clinical variants (26, 27, 43) . The GCI distribution as compared between MSA-C and MSA-P has been a topic of some studies, but a final conclusion has not yet been reached (37, 41, 44) . Elucidation of the temporal changes in the neuropathology of MSA-C and MSA-P may be needed to interpret the differing pathologic profiles.
We analyzed microglial and GCI burdens grouped by neuroanatomic region subdivided into gray and white (Table 5 ). The microglial and GCI burdens were significantly correlated in both subdivisions of MSA-C, MSA-P, and MSA. Furthermore, the degree of correlation in gray matter was similar to that in white matter.
It is presently not known whether GCIs, which very likely contribute to oligodendroglial dysfunction and demyelination, actually form the primary pathologic basis of MSA. Provided this is true, however, how the white matter pathology leads to the gray matter pathology remains unsolved. A hypothesis could be suggested that the white matter pathology subsequent to GCI accumulation in oligodendroglia disrupts the axon, which then damages the neuronal perikarya in a retrograde manner. Whatever the underlying mechanisms, our results indicate that, from the standpoint of microglial activation, GCIs probably have the same importance on gray matter pathology as they do on white matter pathology.
